Literature DB >> 23439376

Optimum nutrition for kidney stone disease.

Ita P Heilberg1, David S Goldfarb.   

Abstract

We summarize the data regarding the associations of individual dietary components with kidney stones and the effects on 24-hour urinary profiles. The therapeutic recommendations for stone prevention that result from these studies are applied where possible to stones of specific composition. Idiopathic calcium oxalate stone-formers are advised to reduce ingestion of animal protein, oxalate, and sodium while maintaining intake of 800 to 1200 mg of calcium and increasing consumption of citrate and potassium. There are few data regarding dietary therapy of calcium phosphate stones. Whether the inhibitory effect of citrate sufficiently counteracts increasing urine pH to justify more intake of potassium and citrate is not clear. Reduction of sodium intake to decrease urinary calcium excretion would also be expected to decrease calcium phosphate stone recurrence. Conversely, the most important urine variable in the causation of uric acid stones is low urine pH, linked to insulin resistance as a component of obesity and the metabolic syndrome. The mainstay of therapy is weight loss and urinary alkalinization provided by a more vegetarian diet. Reduction in animal protein intake will reduce purine ingestion and uric acid excretion. For cystine stones, restriction of animal protein is associated with reduction in intake of the cystine precursor methionine as well as cystine. Reduction of urine sodium results in less urine cystine. Ingestion of vegetables high in organic anion content, such as citrate and malate, should be associated with higher urine pH and fewer stones because the amino acid cystine is soluble in more alkaline urine. Because of their infectious origin, diet has no definitive role for struvite stones except for avoiding urinary alkalinization, which may worsen their development. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439376     DOI: 10.1053/j.ackd.2012.12.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  28 in total

Review 1.  Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

2.  Whey protein and albumin effects upon urinary risk factors for stone formation.

Authors:  Camila Mithie Hattori; Hans-Göran Tiselius; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2017-03-22       Impact factor: 3.436

3.  In vitro anti-lithogenic activity of lime powder regimen (LPR) and the effect of LPR on urinary risk factors for kidney stone formation in healthy volunteers.

Authors:  Pajaree Chariyavilaskul; Poonsin Poungpairoj; Suchada Chaisawadi; Chanchai Boonla; Thasinas Dissayabutra; Phisit Prapunwattana; Piyaratana Tosukhowong
Journal:  Urolithiasis       Date:  2015-01-15       Impact factor: 3.436

Review 4.  Environmental and stressful factors affecting the occurrence of kidney stones and the kidney colic.

Authors:  Rigas G Kalaitzidis; Dimitrios Damigos; Kostas C Siamopoulos
Journal:  Int Urol Nephrol       Date:  2014-06-14       Impact factor: 2.370

Review 5.  The nutrition consult for recurrent stone formers.

Authors:  Kristina L Penniston
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

6.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

Review 7.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 8.  The elementome of calcium-based urinary stones and its role in urolithiasis.

Authors:  Krishna Ramaswamy; David W Killilea; Pankaj Kapahi; Arnold J Kahn; Thomas Chi; Marshall L Stoller
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 9.  Treatment of patients with uric acid stones.

Authors:  Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

10.  Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention.

Authors:  K L Penniston; M L Wertheim; S Y Nakada; R A Jhagroo
Journal:  Eur J Clin Nutr       Date:  2016-05-25       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.